Company Filing History:
Years Active: 2015-2023
Title: Young Mi Kuhlman: Innovator in Pharmaceutical Sciences
Introduction
Young Mi Kuhlman is an accomplished inventor based in Plainsboro, NJ, known for her significant contributions to pharmaceutical sciences. With a total of four patents to her name, she has pioneered processes that may lead to advancements in treating various medical conditions.
Latest Patents
One of Kuhlman's latest patents involves the development of processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and its salts. This innovative compound serves as an S1P1 receptor modulator, which may play a crucial role in treating S1P1 receptor-associated disorders. Such disorders include those mediated by lymphocytes, transplant rejection, various autoimmune diseases, and inflammatory diseases. This patent addresses conditions characterized by underlying defects in vascular integrity and those associated with pathological angiogenesis, such as inflammation, tumor development, and atherosclerosis.
Career Highlights
Young Mi Kuhlman's career is marked by her role at Arena Pharmaceuticals, Inc., where she is an integral part of research and development. Her work emphasizes the importance of innovative processes that can lead to effective treatment options for a variety of health challenges.
Collaborations
Throughout her career, Kuhlman has collaborated with esteemed colleagues, including Antonio Garrido Montalban and Daniel J. Buzard. These partnerships have enhanced her research and contributed to the successful development of her patented processes.
Conclusion
Young Mi Kuhlman's innovative work in the field of pharmaceutical sciences showcases the role of inventors in advancing healthcare solutions. Her contributions through her patents not only highlight her expertise but also offer hope for patients dealing with complex medical conditions. As she continues her work, the impact of her inventions will undoubtedly be felt in the medical community.